2023
DOI: 10.1016/s0168-8278(23)02947-1
|View full text |Cite
|
Sign up to set email alerts
|

Tenofovir prophylaxis during pregnancy for the elimination of mother-to-child transmission of hepatitis B virus: a cost-effectiveness analysis

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles